Topics

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

2017-07-24 12:11:38 | BioPortfolio

Summary

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms similar to HTLV infection.

Description

Post-market, multi-center, study to support a diagnostic sample labeling claim. The Diagnostic Study will assess the performance of the HTLV Blot 2.4 with samples representative of clinical diagnostic samples (HTLV infected and conditions with symptoms similar to that HTLV). This study will use commercially available repository samples from qualified vendors. For neurological specimens not readily available in repository laboratories, prospection collection will be performed to meet the specimen enrollment goals.

Study Design

Conditions

HTLV-I Infections

Intervention

MP Diagnostics HTLV Blot 2.4

Location

LABS, Inc.
Philadelphia
Pennsylvania
United States
19123

Status

Not yet recruiting

Source

MP Biomedicals, LLC

Results (where available)

View Results

Links

Published on BioPortfolio: 2017-07-24T12:11:38-0400

Clinical Trials [488 Associated Clinical Trials listed on BioPortfolio]

Dual Algorithm Post Market Clinical Study

The purpose of this study is to assess the validity and reproducibility of the MP Diagnostics HTLV Blot 2.4 in blood specimens testing repeat reactive (RR) on the first FDA licensed screen...

HTLV-1 Carriers and HTLV-1 Associated Illnesses in Blood Donors in Jamaica

RATIONALE: Collecting information about HTLV-1 carriers and HTLV-1 associated illnesses in blood donors in Jamaica may help doctors learn more about these diseases. PURPOSE: This clinical...

A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)

The objective of this study is to assess the efficacy and safety of KW-0761 after intravenous injections in subjects with HTLV-1 associated myelopathy (HAM) in Japan.

Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM)

HTLV-1 Associated Myelopathy is a chronic disease of the spinal cord, caused by a virus called human T lymphotropic virus type 1(HTLV−1). Natural Killer cells provide rapid responses...

Evaluation of InnoLIA HTLV I/II Score

The InnoLIA HTLV I/II Score is an in vitro diagnostic test for confirmation of antibodies to human T-cell lymphotropic virus (HTLV) type I and type II in human blood samples. It is intend...

PubMed Articles [5272 Associated PubMed Articles listed on BioPortfolio]

HTLV-1 proviral load in infective dermatitis associated with HTLV-1 does not increase after the development of HTLV-1-associated myelopathy/tropical spastic paraparesis and does not decrease after IDH remission.

Infective dermatitis associated with HTLV-1 (IDH) is a recurrent eczema which affects children vertically infected with HTLV-1. In Bahia, Brazil, we recently reported that 47% of IDH patients also dev...

The first survey of human T-cell lymphotropic viruses (HTLV) in HIV/AIDS patients in Santa Catarina State, Brazil.

Santa Catarina is a Brazilian State that has reported the lowest prevalence of human T-cell lymphotropic viruses (HTLV-1/2) in blood donors (0.04%). Although it presents ports, airports and roads that...

Pregnancy does not adversely impact diagnostic tests for HTLV-1/2 infection.

Mother-to-child-transmission (MTCT) of human T-cell lymphotropic virus type-1(HTLV-1) contributes disproportionately to the burden of HTLV-1 associated diseases. All preventive measures to avoid MTCT ...

Development and evaluation of human T-cell leukemia virus-1 and -2 multiplex quantitative PCR.

Diagnosis of human T -cell leukemia virus type 1 (HTLV-1) infection in Japan is usually performed by serological testing, but the high rate of indeterminate results from western blotting makes it diff...

Relevance of HTLV-1 proviral load in asymptomatic and symptomatic patients living in endemic and non-endemic areas of Argentina.

HTLV-1 proviral load (pVL) in peripheral blood mononuclear cell (PBMCs) is proposed as a marker of disease progression but its role still remains controversial. The aim of this study was to evaluate t...

Medical and Biotech [MESH] Definitions

Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED).

Antibodies reactive with the HTLV-II ANTIGENS.

Antibodies reactive with the HTLV-I ANTIGENS.

Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.

Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2.

More From BioPortfolio on "MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study"

Quick Search

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Searches Linking to this Trial